Hosted on MSN1mon
GSK raises long-term guidance, announces buybacks
Meanwhile, GSK’s (NYSE:GSK) full-year revenue grew ~7% YoY to £31.3B as specialty medicines sales jumped 19% YoY and vaccine sales fell ~4% YoY. Meanwhile, its core earnings per share for Q4 ...
Class Action Filed Against GSK plc (GSK) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...